Home > Healthcare > Biotechnology > Biotechnology R&D > Hematopoietic Stem Cell Transplantation Market
Hematopoietic Stem Cell Transplantation Market Share
- Report ID: GMI6276
- Published Date: Jul 2023
- Report Format: PDF
Hematopoietic Stem Cell Transplantation Market Share
The well known, established, prominent players in hematopoietic stem cell transplantation market are:
- Pluristem Therapeutics Inc.
- Sanofi
- Taiga Biotechnologies, Inc
- CellGenix GmbH
- Novartis AG
- Regen Biopharma Inc.
- Kiadis Pharma
- Marker Therapeutics, Inc.
- Escape Therapeutics, Inc.
- GlaxoSmithKline plc
- Merck KGaA
- Bluebird Bio, Inc.
- Talaris Therapeutics.
Frequently Asked Questions (FAQ) :
The Global market size for hematopoietic stem cell transplantation was valued to be USD 2.6 billion in 2022 and is expected to record a CAGR of 9.3% by 2032, owing to the increasing incidence of leukemia, rising success rate of transplantation, and technological advancements.
The autologous transplant therapy segment held the largest market share of 57.6% in 2022 as it reduces the time and resources required for donor search and facilitates a quicker transplantation process.
North America market is expected to reach USD 2.2 billion by 2032 because the region boasts a well-developed and advanced healthcare infrastructure, including specialized transplant centers and comprehensive cancer centers.
Pluristem Therapeutics Inc., Sanofi, Taiga Biotechnologies, Inc., CellGenix GmbH, Novartis AG, Regen Biopharma Inc., Kiadis Pharma, Marker Therapeutics, Inc., Escape Therapeutics, Inc., GlaxoSmithKline plc, Merck KGaA, Bluebird Bio, Inc., and Talaris Therapeutics.
Hematopoietic Stem Cell Transplantation Market Scope
×
Get a free sample of
Hematopoietic Stem Cell Transplantation Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below